- Home
- TELA vs RDI Comparison
TELA vs RDI Comparison
Compare TELA & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELA
- RDI
- Stock Information
- Founded
- TELA 2012
- RDI 1937
- Country
- TELA United States
- RDI United States
- Employees
- TELA N/A
- RDI N/A
- Industry
- TELA Medical/Dental Instruments
- RDI Movies/Entertainment
- Sector
- TELA Health Care
- RDI Consumer Discretionary
- Exchange
- TELA Nasdaq
- RDI Nasdaq
- Market Cap
- TELA 36.4M
- RDI 30.1M
- IPO Year
- TELA 2019
- RDI N/A
- Fundamental
- Price
- TELA $1.68
- RDI $1.36
- Analyst Decision
- TELA Strong Buy
- RDI Hold
- Analyst Count
- TELA 4
- RDI 1
- Target Price
- TELA $6.00
- RDI $2.40
- AVG Volume (30 Days)
- TELA 181.8K
- RDI 31.5K
- Earning Date
- TELA 08-11-2025
- RDI 08-13-2025
- Dividend Yield
- TELA N/A
- RDI N/A
- EPS Growth
- TELA N/A
- RDI N/A
- EPS
- TELA N/A
- RDI N/A
- Revenue
- TELA $71,217,000.00
- RDI $205,644,000.00
- Revenue This Year
- TELA $26.67
- RDI $7.47
- Revenue Next Year
- TELA $22.63
- RDI $13.22
- P/E Ratio
- TELA N/A
- RDI N/A
- Revenue Growth
- TELA 12.78
- RDI N/A
- 52 Week Low
- TELA $0.86
- RDI $1.17
- 52 Week High
- TELA $5.56
- RDI $1.89
- Technical
- Relative Strength Index (RSI)
- TELA 55.94
- RDI 48.35
- Support Level
- TELA $1.48
- RDI $1.38
- Resistance Level
- TELA $1.80
- RDI $1.38
- Average True Range (ATR)
- TELA 0.21
- RDI 0.06
- MACD
- TELA -0.03
- RDI -0.01
- Stochastic Oscillator
- TELA 49.33
- RDI 25.00
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.